CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
We are very excited to launch our new website! Please take a few moments to click around and explore...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...